Photoshopping for an unrealistic body image has gone too far

 

Today Health

When thigh gaps attack: Target's Photoshop fail goes viral

Melissa Dahl TODAY

March 11, 2014 at 3:26 PM ET

Target.com

Attack of the thigh gap! Yesterday, an observant blogger called out some pretty egregious Photoshop shenanigans on Target’s website; we fear the thigh gap on this particular swimsuit model will not rest until it consumes her entire body.
By Tuesday morning, other, bigger sites like Jezebel and the New York Daily News had piled on. (We reached out to Target for a comment but did not immediately hear back.) And by Tuesday afternoon, the retailer had removed the images from its website. Speedy work, Internet.
“I love how quickly it got called out,” says Pamela Rutledge, a psychologist and director of the Media Psychology Research Center. “Social norms are enforced by community, and that’s true in a club, in a church, or society wide; and now society, because of the Internet, is very broad. And there’s a lot of sensitivity for stuff like this.”
In our TODAY/AOL Body Image survey, released last month, we found that the majority of the teen girls we surveyed said they wished that Photoshopping would stop entirely. Because those images that girls see in the media have a real impact on the way they feel about themselves; 80 percent of the teenage girls we surveyed said they compare themselves to the images they see of celebrities, and many of those girls said those images made them feel worse about their own appearances. On Jezebel, writer Rebecca Rose took particular issue with the fact that this is an item in the juniors' department:....

Read More Here

.....

Cosmopolitan

Old Navy Photoshops Thigh Gaps Onto Plus-Size Denim

March 17, 2014 at 6:19PM by Anna Breslaw

Oh! Cool. So, uh, thigh gap is still a thing that's happening. Old Navy is the most recent retailer caught Photoshopping thigh gaps — specifically, onto the plus-size jeans displayed in their online store, reports Jezebel.

At first glance, it looks like the jeans simply could have been pinned on the display mannequin, but if you look closer, you can see it's a (shoddy) Photoshop job.

Read More Here
......

Jezebel

Land's End Catalog Cover Photoshops Perfect Dorito-Shaped Thigh Gap

Erin Gloria Ryan

Erin Gloria Ryan

Thursday 12:20pm

Expand

It pains me to be the bearer of tragic news, but it appears that another brutal catalog swimsuit model thigh gapping has occurred. This one's on the cover of the latest Land's End catalog.

A reader alerted us (and a staffer who still gets catalogs in the mail* confirmed) that this month's LE did some creative limb-chopping with the the woman in the one piece bathing suit on its cover. Note the oddly angular thigh gap, and the disparity in the size of her thighs; her left thigh is oddly oranger and slimmer than her right one. Also human legs don't look like that.

Read More Here
.....

Related articles

• When thigh gaps attack: Target's Photoshop fail goes viral - Today.com
• Old Navy Photoshops Thigh Gaps Onto Plus-Size Denim
• Stop going on about the 'thigh gap', and please stop photoshopping it in
• Old Navy Photoshops Thigh Gaps Onto Their Plus-Size Jeans
• Old Navy Accused of Photoshopping Thigh Gaps on Their Plus-Size Models--But They Have an Explanation!
• The Latest Photoshop Fail
• Forget the fakery! Teens tell us they're not cool with Photoshop

Helados La Tapatia Recalls Ice Cream for Possible Listeria

Food Poisoning Bulletin

March 20, 2014 by Linda Larsen

Helados La Tapatia, Inc. is recalling ice cream, popsicles, fruit bars and cups, adn bolis because they may be contaminated with Listeria monocytogenes. No illnesses have been reported to date, but listeriosis can take up to 70 days after exposure to make someone sick.

The products include Fruit Bars, Milk Bars, Bolis, Ice Cream Containers, Ice Cream Cups, Ice Cream Sandwiches, and Frutero. The recalled products were sold in Arizona, California, Nevada, Washington, Guam, and Canada in retail stores. The products are sold under the brand names of Helados La Tapatia and Icesations.


 Read More Here

Related articles

• Fresno company Helados La Tapatia recalls ice cream treats
• California Ice Cream Recalled over Listeria Concerns
• Listeria prompts recall of ice cream, fruit products by California company

Terra-Medica Recalls Dietary Supplements for Undeclared Penicillin

Food Poisoning Bulletin

March 20, 2014 by Kathy Will  

Terra-Medica is recalling 56 lots of homoepathic drug products because they may have the drug penicillin that is not declared on the label.

Anyone who is allergic to penicillin, or allergic to beta-lactam antibiotics, even at low levels, could have a serious or life-threatening anaphylactic reaction if they consume these products. The penicillin or derivatives of penicillin could be produced during the fermentation process. No reports of adverse reactions have been reported to date.

Read More Here

.....

U.S. Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
1-888-INFO-FDA (1-888-463-6332)
Contact FDA

Recall -- Firm Press Release

FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.

Terra-Medica Issues Voluntary Nationwide Recall of Specified Lots of Pleo Homeopathic Drug Products Due to the Potential for Undeclared Penicillin

Contact:
Consumer:
1-888-415-0535
terry@biomedicine.com

FOR IMMEDIATE RELEASE - March 18, 2014 - Terra-Medica, Inc. is voluntarily recalling 56 lots of Pleo-FORT, Pleo-QUENT, Pleo-NOT, Pleo-STOLO, Pleo-NOTA-QUENT, and Pleo-EX homeopathic drug products in liquid, tablet, capsule, ointment, and suppository forms to the consumer level. FDA has determined that these products have the potential to contain penicillin or derivatives of penicillin, which may be produced during the fermentation process.

In patients who are allergic to beta-lactam antibiotics, even at low levels, exposure to penicillin can result in a range of allergic reactions from mild rashes to severe and life-threatening anaphylactic reactions. To date, Terra-Medica has not received any reports of adverse events related to this recall, nor any reports of product tests indicating penicillin content in the products.
The products are used as homeopathic drugs and have a label stating “Distributed by SANUM USA Corp.” The affected products are identified by package size, batch (lot) number and expiry date (ranging from March 2014 – May 2018) in the table accompanying this release. The batch number can be located at the side panel on the label. The affected products were distributed nationwide through health care practitioners, who may have sold the products through websites.
Terra-Medica is notifying its customers by letter and email and is arranging for return of all recalled products. Consumers and distributors that have product which is subject to the recall should stop using the products and return them to the point of purchase.
Consumers with questions regarding this recall can contact Terra-Medica’s Customer Service Department at (888) 415-0535, ext. 1, Monday through Friday between 8-5pm, Pacific Time Zone, or their health care practitioner that distributed the product. Consumers should contact their physician or healthcare provider if they have experienced reactions while taking or using this drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to Terra Medica or the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Online:www.fda.gov/medwatch/report.htm
• Regular Mail: use postage-paid, pre-addressed Form FDA 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail to address on the pre-addressed form.
• Fax: 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Product Name	Potency	Pharmaceutical Form	Package Size	Batch #	Expiry Date
PLEO-NOT	5X	Portable sips	10 x 1ml	07099	08/2014
PLEO-NOT	5X	Portable sips	10 x 1ml	15090	08/2015
PLEO-NOT	5X	Portable sips	10 x 1ml	06120	11/2015
PLEO-NOT	5X	Portable sips	10 x 1ml	19023	01/2018
PLEO-NOT	5X	Portable sips	50 x 1ml	07099	08/2014
PLEO-NOT	5X	Portable sips	50 x 1ml	15090	08/2014
PLEO-NOT	5X	Portable sips	50 x 1ml	01110	10/2015
PLEO-NOT	5X	Portable sips	50 x 1ml	06120	11/2015
PLEO-NOT	5X	Portable sips	50 x 1ml	19023	01/2018
PLEO-NOT	6X	Portable sips	10 x 1ml	25050	04/2015
PLEO-NOT	6X	Portable sips	50 x 1ml	25050	04/2015
PLEO-NOT	7X	Portable sips	10 x 1ml	20010	12/2014
PLEO-NOT	7X	Portable sips	50 x 1ml	20010	12/2014
PLEO-NOT	5X	Drops	10ml	21049	03/2014
PLEO-NOT	5X	Drops	10ml	13059	04/2014
PLEO-NOT	5X	Drops	10ml	09080	07/2015
PLEO-NOT	5X	Drops	10ml	15100	09/2015
PLEO-NOT	5X	Drops	10ml	24092	08/2017
PLEO-NOT	5X	Tablets	20pcs	15070	06/2015
PLEO-NOT	5X	Tablets	20pcs	24072	06/2017
PLEO-NOT	3X	Ointment	30g	03051	04/2014
PLEO-NOT	3X	Ointment	30g	13072	06/2015
PLEO-NOT	3X	Ointment	30g	21033	04/2016
PLEO-NOT	3X	Suppositories	10pcs	1080	07/2015
PLEO-NOT	3X	Suppositories	10pcs	1102	09/2017
PLEO-NOT	4X	Capsules	20pcs	14010	12/2014
PLEO-NOT	4X	Capsules	20pcs	11080	08/2015
PLEO-NOT	4X	Capsules	20pcs	12092	07/2017
PLEO-NOTA-QUENT	5X	Drops	10ml	04062	05/2017
PLEO-NOTA-QUENT	5X	Drops	10ml	06062	05/2017
PLEO-QUENT	5X	Portable sips	10 x 1ml	13090	08/2015
PLEO-QUENT	5X	Portable sips	50 x 1ml	13090	08/2015
PLEO-QUENT	5X	Drops	10ml	15129	11/2014
PLEO-QUENT	5X	Drops	10ml	12040	03/2015
PLEO-QUENT	5X	Drops	10ml	01081	08/2016
PLEO-QUENT	4X	Capsules	20pcs	25030	04/2015
PLEO-QUENT	4X	Capsules	20pcs	27101	09/2016
PLEO-QUENT	3X	Suppositories	10pcs	2089	06/2014
PLEO-QUENT	3X	Suppositories	10pcs	3031	03/2016
PLEO-FORT	5X	Portable sips	10 x 1ml	15030	02/2015
PLEO-FORT	5X	Portable sips	10 x 1ml	12122	11/2017
PLEO-FORT	5X	Portable sips	50 x 1ml	15030	02/2015
PLEO-FORT	5X	Portable sips	50 x 1ml	12122	11/2017
PLEO-FORT	5X	Drops	10ml	23109	09/2014
PLEO-FORT	5X	Drops	10ml	08030	02/2015
PLEO-FORT	5X	Drops	10ml	12032	02/2017
PLEO-FORT	5X	Drops	10ml	26043	03/2018
PLEO-FORT	5X	Tablets	20 pcs	27100	09/2015
PLEO-FORT	5X	Tablets	20 pcs	29100	10/2015
PLEO-FORT	5X	Tablets	20 pcs	25013	01/2018
PLEO-FORT	3X	Suppositories	10pcs	3110	10/2015
PLEO-FORT	3X	Suppositories	10pcs	1112	10/2017
PLEO-FORT	4X	Capsules	20pcs	24030	02/2015
PLEO-FORT	4X	Capsules	20pcs	14062	05/2017
PLEO-EX	5X	Portable sips	10 x 1ml	09020	01/2015
PLEO-EX	5X	Portable sips	10 x 1ml	03052	04/2017
PLEO-EX	5X	Portable sips	50 x 1ml	09020	01/2015
PLEO-EX	5X	Portable sips	50 x 1ml	03052	04/2017
PLEO-EX	5X	Drops	10ml	07011	12/2015
PLEO-EX	5X	Drops	10ml	09043	03/2018
PLEO-EX	3X	Suppositories	10pcs	2011	12/2015
PLEO-EX	3X	Suppositories	10pcs	2081	07/2016
PLEO-EX	3X	Suppositories	10pcs	3063	05/2018
PLEO-EX	3X	Suppositories	10pcs	1013	02/2018
PLEO-STOLO	6X	Drops	10ml	08060	05/2015
PLEO-STOLO	6X	Drops	10ml	07119	08/2014
PLEO-STOLO	6X	Drops	10ml	03043	05/2018

###

RSS Feed for FDA Recalls Information [what's this?]

Photo: Product Labels
Recalled Product Photos Are Also Available on FDA's Flickr Photostream.
    

Page Last Updated: 03/20/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Related articles

• Terra-Medica Issues Voluntary Nationwide Recall of Specified Lots of Pleo Homeopathic Drug Products Due to the Potential for Undeclared Penicillin

Fascinating New Study Shows How Emotions Are Mapped On The Human Body

Jan 7, 2014 by MICHAEL FORRESTER

Prevent Disease

Emotions coordinate our behavior and physiological states during survival-salient events and pleasurable interactions. Even though we are often consciously aware of our current emotional state, such as anger or happiness, the mechanisms giving rise to these subjective sensations have remained unresolved. Brilliant research by Finnish scientists has mapped the areas of our body that are experiencing an increase or decrease in sensory activity when we experience a particular emotion.

In a new study, Finnish researchers have published visualizations describing how human emotions affect the body.  PNAS

Depending on whether we are happy, sad or angry, we have physiological sensations that are not located in different areas of the body. We overlook this reality from one day to the next (the famous "lump in the breast" generated by anxiety, the feeling of warmth that pervades our face and our cheeks particularly when we feel the shame...), and do not consciously realize how much the location of these body areas activated by our emotions and how they vary considerably depending on the nature of the emotion.

Researchers around the world are slowly integrating research on how our energetic and emotional states cause health and/or disease. How we connect emotionally to our overall wellness and wellbeing may indeed be more relevant than any supplement, food, exercise, medical intervention or health treatment.
Finnish scientists have for the first time mapped areas of the body activated according to each emotion (happiness, sadness, anger, etc). This map was compiled following a study of 700 Finnish, Swedish and Taiwanese volunteers.
They used a topographical self-report tool to reveal that different emotional states are associated with topographically distinct and culturally universal bodily sensations; these sensations could underlie conscious emotional experiences. Monitoring the topography of emotion-triggered bodily sensations brings forth a unique tool for emotion research and could even provide a biomarker for emotional disorders.
Read More Here

Related articles

• Bodily maps of emotions
• Bodily maps of emotions

Drexel Death Tied to Strain Behind Outbreaks

• NBC News

By JoNel Aleccia

A Drexel University sophomore who died Monday was infected with the same strain of meningococcal bacteria that prompted emergency vaccination clinics at two U.S. universities in recent months.

Courtesy of Ross family

Drexel University student Stephanie Ross died suddenly Monday from a meningococcal infection caused by the B strain of bacteria not covered by vaccines available in the U.S.

Stephanie Ross’ bloodstream infection, called meningococcemia, was caused by the B strain of the bacteria, Pennsylvania state health officials confirmed Thursday. That strain is not covered by the meningitis vaccine available in the U.S. — and required for students in campus housing at Drexel — to protect college students and others against the potentially deadly infection.

The mechanical engineering major from Pittsburgh was discovered unresponsive by housemates at her sorority Monday and rushed to a local hospital, where she died.

Outbreaks of meningitis B at Princeton University and the University of California, Santa Barbara, prompted federal health officials to seek special permission to use Bexsero, an imported vaccine not approved in the U.S. that covers that strain.

Read More Here

Related articles

• Meningitis Strain From Princeton University Outbreak Kills Drexel Student
• Drexel University Student Who Died From Meningitis Was Infected With Princeton Strain: CDC
• Drexel Death Tied to Strain Behind Outbreaks
• Princeton Meningitis Strain Killed Drexel Student, CDC Says
• Drexel Student Dies From Meningococcal Infection
• Death tied to Princeton outbreak

Carcinogen Blocking Effects of Turmeric Curcumin

NutritionFacts.org

Published on Mar 14, 2014

Subscribe for free to Dr. Greger's videos at:
http://bit.ly/nutritionfactsupdates

DESCRIPTION: Less than a teaspoon a day of turmeric appears to significantly lower the DNA mutating ability of cancer-causing substances.
This is second of a three-part video series on turmeric curcumin and its relationship to cancer. To find out more, check out the prequel Back to Our Roots: Curry and Cancer (http://nutritionfacts.org/video/back-...) and the last video in the series Turmeric Curcumin Reprogramming Cancer Cell Death.
Smokers are common research subjects for carcinogen studies. For example, see what happens to carcinogen levels when those eating processed meat start eating vegetarian in my video Heterocyclic Amines in Eggs, Cheese, and Creatine? (http://nutritionfacts.org/video/heter...).
Other foods that may protect DNA include kiwifruit (Kiwifruit and DNA Repair, http://nutritionfacts.org/video/kiwif...), cruciferous vegetables (DNA Protection from Broccoli, http://nutritionfacts.org/video/dna-p...), leafy vegetables (Eating Green to Prevent Cancer, http://nutritionfacts.org/video/eatin...), garlic (Cancer, Interrupted: Garlic & Flavonoids, http://nutritionfacts.org/video/cance...), green tea (Cancer, Interrupted: Green Tea, http://nutritionfacts.org/video/cance... (but which is better? Antimutagenic Activity of Green Versus White Tea, http://nutritionfacts.org/video/antim...)), and plants in general (Repairing DNA Damage, http://nutritionfacts.org/video/repai...).
More information on cancer prevention, treatment, and reversal can be found in my two latest annual presentations Uprooting the Leading Causes of Death (http://nutritionfacts.org/video/uproo...) and More Than an Apple a Day: Combating Common Diseases (http://nutritionfacts.org/video/more-...).
Have a question for Dr. Greger about this video? Leave it in the comment section at http://nutritionfacts.org/video/carci... and he'll try to answer it!

Related articles

• Breast Cancer Survival Vegetable
• Carcinogen blocking effects of tumeric curcumin (3 min. 32 sec. video)
• Turmeric and curcumin prevent formation of new blood vessels induced by arsenic, cancer
• The Benefits of Curcumin in Cancer Treatment
• Strawberries versus Esophageal Cancer
• Reasons Why Doctors Are So Amazed With Curcumin Extract‏
• Winter Antidotes - Hot Turmeric Milk Drink

Company Makes Drug Available To Ailing Boy Following Public Outcry

• CBSNews.com

March 11, 2014, 10:08 PM

Young cancer survivor will get experimental treatment

A 7-year-old boy who has beaten cancer four times but whose weakened immune system is being threatened by a rare virus will start receiving an experimental treatment within 48 hours after the drug's manufacturer reached an agreement with federal officials for a pilot trial to begin immediately.
The boy, Josh Hardy, will be the first patient to be enrolled Wednesday in the new study of the drug, brincidofovir, the Durham, N.C.-based company, Chimerix, announced late Tuesday.
Earlier the company had said it could not release the drug to Josh outside of clinical trials. The boy's family had been pleading with the company to change its mind.

Josh Hardy is seen in this undated photo from the SaveJosh Facebook page. Used with permission from William Burns

Personal photo

The U.S. Food and Drug Administration agreed to the pilot trial of brincidofovir for the treatment of adenovirus infections in immune-compromised patients, the company said in a statement late Tuesday. The FDA will work expeditiously with Chimerix to design a Phase 3 study that would be a continuation of the pilot trial, the company said.
"Josh Hardy's story brought to public attention the often-devastating impact of adenovirus infection, and helped accelerate a discussion between the FDA and Chimerix regarding the need for additional clinical development to assess brincidofovir's potential in adenovirus infection," Kenneth I. Moch, Chimerix's president and CEO, said in a statement.
Read More Here

.....

FORBES

Matthew Herper Forbes Staff

Pharma & Healthcare 3/11/2014 @ 9:12PM 4,486 views

Company Makes Drug Available To Ailing Boy Following Public Outcry

Chimerix, a small and unprofitable biotechnology company, will make an experimental drug available to a young Virginia boy who is suffering from an infection he contracted while being treated for cancer.
Chimerix originally said it could not ethically provide the drug to one patient without opening the floodgates to others, presenting it with a huge operational burden that might prevent the drug, brincidofovir, from ever reaching patients. The story of the boy, Joshua Hardy, was shared on CNN, USA Today, The Huffington Post, and generated a large volume of posts on the social networking site Twitter under the hashtag #savejosh. This evening, Chimerix, based in Durham, North Carolina, issued a press release saying that it was going to start a new, 20-patient clinical trial for the treatment of adenovirus (the virus brincidofovir treats) in immunocompromised patients. The first immunocompromised patient, dosed tomorrow morning, will be Josh Hardy.
“This 20-patient open-label study underscores Chimerix’s mission to develop innovative antiviral therapies in areas of high unmet need – for everyone,” said Chimerix Chief Executive Kenneth I. Moch in his company’s press release. “Being unable to fulfill requests for compassionate use is excruciating, and not a decision any one of us ever wants to have to make. It is essential that each individual in a health crisis be treated with equal gravity and value, a principle we have upheld by pursuing further clinical study of brincidofovir that will inform its use in adenovirus and other serious DNA viral infections.”


Read More Here

Related articles

• Chimerix to Provide Brincidofovir to Josh Hardy as First Patient in New Open-Label Study in ...
• Young cancer survivor will get experimental treatment
• Company Makes Drug Available To Ailing Boy Following Public Outcry
• Josh Hardy Becomes First Patient in Adenovirus Study
• Company: Ailing 7-year-old in Tennessee will get drug as part of study
• Company Reverses Course, Decides To Give Experimental Drug To Young Boy After Initially Denying Request
• Dying boy will get drug as part of study
• 7-year-old Cancer Patient To Receive Experimental Drug
• Family Pleads With Chimerex For Unapproved Drug To Save Boy's Life: How Brincidofovir Could Treat Adenovirus
• BREAKING NEWS In reversal, drug firm to provide meds to dying boy